Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Phase Ib Open-Label Study Of VAY736 & Ibrutinib In Pts W/ CLL On Ibrutinib Therapy

Protocol: OSU-17363

Full Title

Phase Ib open-label study of VAY736 and ibrutinib in patients with chronic lymphocytic leukemia (CLL) on ibrutinib therapy

Leukemia Chronic Lymphocytic Leukemia